Citations Report
Citations Report - Drug Designing: Open Access [127 Articles]
The articles published in Drug Designing: Open Access have been cited 127 times by eminent researchers all around the world. Following is the list of articles that have cited the articles published in Drug Designing: Open Access.
Dey A, Chatterjee SS, Kumar V. A bioassay system for pharmacological standardization of Withania somnifera derived herbal remedies. TANG [HUMANITAS MEDICINE]. 2019;9: 1. |
|
Dey A, Chatterjee SS, Kumar V. Triethylene glycol-like effects of Ashwagandha (Withania somnifera (L.) Dunal) root extract devoid of withanolides in stressed mice. Ayu. 2018;39: 230. |
|
Benfenati E, Roncaglioni A, Lombardo A, Manganaro A. Integrating QSAR, Read-Across, and Screening Tools: The VEGAHUB Platform as an Example. InAdvances in Computational Toxicology 2019. |
|
Palaniswamy R, Padma PR. Molecular Docking Studies of Derivatives of Majorana hortensis Leaves against Anti Apoptotic Targets. |
|
Sonego MS, Segatto NV, Damé L, Fronza M, Gomes CB, Oliveira TL, et al. 7-Chloroquinoline-1, 2, 3-Triazoyl Carboxamides Induce Cell Cycle Arrest and Apoptosis in Human Bladder Carcinoma Cells. Investigational new drugs. 2019;6:1. |
|
Waghmare S, Sherkhane A, Gomase V (2015) Computational mapping of MHC class binding nonamers from Fatty-acid and retinol-binding protein 1 of Brugia malayi. Journal of Basic Sciences 1: 45-53. |
|
Mamillapalli V (2016) Nanoparticles for Herbal Extracts. Asian Journal of Pharmaceutics (AJP): Free full text articles from Asian J Pharm 10. |
|
Tashima T (2015) Possibilities of Cancer Chemotherapy Based on Transporter-Conscious Drug Design. J Carcinog Mutagen 6: 2. |
|
Tashima T (2015) Intriguing possibilities and beneficial aspects of transporter-conscious drug design. Bioorganic & medicinal chemistry 23: 4119-4131. |
|
Divya A. Research and Reviews: Journal of Pharmacology and Toxicological Studies. |
|
Bielecka AM, Obuchowicz E (2016) Antidepressant drugs can modify cytotoxic action of temozolomide. European Journal of Cancer Care. |
|
Li L, Wang J, Zang H, Zhang H, Jiang W, et al. Research and Reviews: Journal of Pharmacy and Pharmaceutical Sciences. |
|
Gautami, J., Nadu, T. Research and Reviews: Journal of Pharmaceutics and Nanotechnology. |
|
Montes, R., Bernat, B., & Srebalus-Barnes, C. (2016). Statistical Applications for Biosimilar Product Development. In Statistical Applications from Clinical Trials and Personalized Medicine to Finance and Business Analytics: Selected Papers from the 2015 ICSA/Graybill Applied Statistics Symposium, Colorado State University, Fort Collins (pp. 259-277). Springer International Publishing. |
|
Burdick, R. K., LeBlond, D. J., Pfahler, L. B., Quiroz, J., Sidor, L., Vukovinsky, K., & Zhang, L. (2017). Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry. |
|
Chow, S. C., Song, F., & Bai, H. (2016). Sample Size Requirement in Analytical Studies for Similarity Assessment. Journal of Biopharmaceutical Statistics, (just-accepted). |
|
Krause, S. O. Reducing Analytical Method Steps for Accelerated Product. |
|
Burdick, R. K., LeBlond, D. J., Pfahler, L. B., Quiroz, J., Sidor, L., Vukovinsky, K., & Zhang, L. (2017). Analytical Comparability and Similarity. In Statistical Applications for Chemistry, Manufacturing and Controls (CMC) in the Pharmaceutical Industry (pp. 329-369). Springer International Publishing. |
|
Burdick, R. K., Thomas, N., & Cheng, A. (2017). Statistical Considerations in Demonstrating CMC Analytical Similarity for a Biosimilar Product. Statistics in Biopharmaceutical Research, (just-accepted). |
|
Burdick, R., Coffey, T., Gutka, H., Gratzl, G., Conlon, H. D., Huang, C. T., ... & Kuehne, H. (2017). Statistical Approaches to Assess Biosimilarity from Analytical Data. The AAPS Journal, 19(1), 4-14. |
|